Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
Clinical trial NCT02597803 · COMPLETED
Trial details
- NCT number
- NCT02597803
- Sponsor
- ReGenTree, LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.